The SASSI Institute conducted a validation project on the accuracy of the adolescent SASSI substance use screening measure with respect to the most current nationally accepted diagnostic standards for substance use disorders, the Diagnostic and Statistical Manual of Mental Disorders diagnostic criteria (DSM-5). We are delighted to report that our data analyses is complete and presently we are preparing our findings for peer review submission and subsequent publication and dissemination.
Decision rules were formulated that would provide a good degree of accuracy using our development sample. Yet, the crucial issue is whether the SASSI-A3 scoring rules would be accurate when applied to a sample not used in formulating the decision rules. That is, how well does the SASSI-A3 cross-validate? When tested, we are pleased to report that the SASSI-A3 decision rules on the cross-validation sample results indicated an overall accuracy of 93.41%, 15.01% gain in sensitivity, 0.83% loss in specificity, and 9.75% gain in overall accuracy!
When released, SASSI-A3 will now include updated language reflecting current teen drug trends, a prescription drug abuse scale, as well as additional items. Once the publication review process is finalized, we are looking forward to making this updated tool available to professionals in the field.
We want to once again acknowledge and thank all the individuals and organizations who provided us with their valuable contributions.
Scarlett Baker, A.A. – SASSI A-3 Project Director, and SASSI Institute Director of Training
The SASSI Institute wishes to express our appreciation for those working in correctional settings, criminal justice and juvenile services. This is an unprecedented time for all, and especially hard for those working in correctional settings and their family members. Thank you for staying strong!
We also send our condolences to the family and friends of those who have lost their life during this pandemic.
Stay safe everyone.
Due to the continuing
outbreak of COVID-19 cases throughout the world, infectious disease experts
have recommended reducing face-to-face contact and social distancing as much as
possible to avoid spreading the virus. Many counseling and treatment providers are
now looking to boost their adoption of virtual communication (telehealth) as a
tool during this time. Congress also recently passed legislation allowing
professionals to bill Medicare for patient care delivered by telehealth during
the current coronavirus public health emergency (congress.gov).
intervention saves lives, it is vital that screening individuals for SUD
not get delayed during this pandemic and that access to treatment be available.
If you are not already aware, the adult, adolescent, and Spanish SASSI screening
tools can be administered to a client remotely via SASSI Online. Choose the
“Email direct link to client” option when assigning a questionnaire
administration, and your client can complete it at their location via the
If you are
not currently a SASSI Online user and would like to try it risk-free, please
contact our customer service team at 800.726.0526 or email@example.com.
for all the work you do!